Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSCW) Non-Current Deffered Revenue (2020)

Historic Non-Current Deffered Revenue for Ensysce Biosciences (ENSCW) over the last 1 years, with Q4 2020 value amounting to $6.8 million.

  • Ensysce Biosciences' Non-Current Deffered Revenue changed N/A to $6.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $6.8 million, marking a year-over-year change of. This contributed to the annual value of $6.8 million for FY2020, which is N/A changed from last year.
  • Per Ensysce Biosciences' latest filing, its Non-Current Deffered Revenue stood at $6.8 million for Q4 2020.
  • Over the past 5 years, Ensysce Biosciences' Non-Current Deffered Revenue peaked at $7.0 million during Q1 2020, and registered a low of $6.8 million during Q4 2020.